Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Burden of liver diseases in the world
2018 Standout
Fibrosis and Adipose Tissue Dysfunction
2013 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Hepatitis delta virus
2011
Molecular Characterization of Pancreatic Neoplasms
2008
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
2006
Management of the critically ill patient with severe acute pancreatitis
2004
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
2015
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
2006
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Gout
2016 Standout
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
2011
Chronic hepatitis B: Update 2009 #
2009 Standout
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
2016
Hepatitis C and renal disease: an update
2003
Liver Fibrosis during an Outbreak of Acute Hepatitis C Virus Infection in HIV‐Infected Men: A Prospective Cohort Study
2008
Practice Guidelines in Acute Pancreatitis
2006 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
2005
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
2008
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Does Serum Procalcitonin Have a Role in Evaluating the Severity of Acute Pancreatitis? A Question Revisited
2006
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Meta‐analysis: antiviral treatment for hepatitis D
2012
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Short-Term Overfeeding May Induce Peripheral Insulin Resistance Without Altering Subcutaneous Adipose Tissue Macrophages in Humans
2010
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
2012 Standout
Works of Gül Yüce being referenced
Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study
2009
Is procalcitonin a reliable marker for the diagnosis of infected pancreatic necrosis?
2004
Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis
2003
Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients
1998
Infliximab:
2003
Two-Year Interferon Therapy with Or without Ribavirin in Chronic Delta Hepatitis
2005
Interferon–Lamivudine Combination is No Better than Lamivudine Alone in Anti-Hbe-Positive Chronic Hepatitis B
2004
Allopurinol hypersensitivity syndrome as a cause of hepatic centrilobular hemorrhagic necrosis.
2003
Osteoclast-type giant cell tumor of the pancreas associated with mucinous cystadenoma.
1993